SCHEMBL3048546

SCHEMBL3048546

Nc1ccc(-c2ccco2)c2c1C(=O)NC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.45
TDP2 O95551 2/20 0.37
BRD4 O60885 1/20 0.36
MAP3K9 P80192 2/20 0.35
MAP3K11 Q16584 2/20 0.35
CSF1R P07333 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PIM1 P11309 1/20 0.33
CSNK1A1 P48729 1/20 0.33
CDK5 Q00535 1/20 0.33
ROCK1 Q13464 1/20 0.33
DYRK1A Q13627 1/20 0.33
LRRK2 Q5S007 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
CFTR P13569 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3034051 0.83 TDP2 (0.37) KDRTDP2BRD4MAP3K9MAP3K11
SCHEMBL18170632 0.77 TDP2 (0.41) TDP2BRD4ADORA2AADORA1MAPT
SCHEMBL3043388 0.76 KDR (0.54) KDRMAP3K9MAP3K11CSF1RADORA2A
SCHEMBL21436497 0.74 THRB (0.42) KDRMAP3K9MAP3K11CSF1RADORA2A
SCHEMBL18170563 0.74 KDR (0.61) KDRMAP3K9MAP3K11CSF1RPIM1
SCHEMBL18170916 0.73 KDR (0.57) KDRADORA2AMAPTKDM4EMEN1
SCHEMBL18170546 0.72 KDR (0.50) KDRMAP3K9MAP3K11CSF1RMAPT
SCHEMBL30701043 0.72 KDR (0.50) KDRMAP3K9MAP3K11CSF1RMAPT
SCHEMBL3047923 0.71 CDK5 (0.62) KDRMAP3K9MAP3K11CSF1RADORA2A
SCHEMBL18170605 0.71 KDR (0.48) KDRADORA1MAPTTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 KDR 3226/4885TDP2 4292/4885BRD4 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.